FDA: Convenience Kit Correction: Medline Issues Correction for Kits Containing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP

Published: 06/12/2026

Sources:
  • Food and Drug Administration
Relevant To:
  • Ambulatory Surgical Centers,
  • Rural Emergency Hospitals,
  • Urgent Care,
  • Critical Access Hospitals,
  • Hospitals,
  • Office-Based Surgery,
  • Rural Health Clinics

The Food and Drug Administration (FDA) is aware that Medline has issued a letter to affected customers recommending certain convenience kits be corrected prior to continued use by removing included Bupivacaine Hydrochloride in Dextrose Injections.

Medline Industries is removing Huons Bupivacaine Hydrochloride in Dextrose Injection, USP from certain convenience kits. Huons Co., Ltd. initiated a recall of Bupivacaine HCL in Dextrose Injection, USP following a recent FDA inspection of its manufa…

Sign Up for Free Trial